期刊
BIOORGANIC & MEDICINAL CHEMISTRY
卷 66, 期 -, 页码 -出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2022.116820
关键词
Medicinal chemistry; Nucleoside; Cyclonucleoside; PRMT5; PRMT5 inhibitor; X-ray crystallography; Molecular modeling
资金
- Merck Sharp Dohme Corp.
The design and synthesis of unprecedented 9- and 10-membered purine 8,5' cyclonucleosides as the first cyclonucleoside PRMT5 inhibitors is reported. The cocrystal structure of PRMT5:MEP50 in complex with the synthesized 9-membered cyclonucleoside 1 revealed its binding mode in the SAM binding pocket of PRMT5.
Synthesis of medium-sized rings is known to be challenging due to high transannular strain especially for 9- and 10-membered rings. Herein we report design and synthesis of unprecedented 9- and 10-membered purine 8,5 ' cyclonucleosides as the first cyclonucleoside PRMT5 inhibitors. The cocrystal structure of PRMT5:MEP50 in complex with the synthesized 9-membered cyclonucleoside 1 revealed its binding mode in the SAM binding pocket of PRMT5.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据